Utility of hematological and biochemical parameters as a screening tool for assessing coronavirus disease 2019 infection and its severity

Background: The rapidly evolving pandemic of Coronavirus disease 2019 (COVID-19) has presented with clinical severity, which varies from asymptomatic cases to being fatal in others. The need of the hour is to find meaningful and cost-effective COVID-19 biomarkers out of conventional hematological an...

Full description

Saved in:
Bibliographic Details
Published in:The journal of microscopy & ultrastructure 2024-10, Vol.12 (4), p.214
Main Authors: Alam, Sana, Khan, Sabina, Jain, Vineet, Kashyap, Varun, Kapur, Prem
Format: Article
Language:English
Subjects:
China
Coronaviruses
Diagnosis
Diseases
Epidemics
Health aspects
India
Lymphocytes
Medical research
Medical screening
Medical tests
Medicine, Experimental
Prognosis
Urea
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: The rapidly evolving pandemic of Coronavirus disease 2019 (COVID-19) has presented with clinical severity, which varies from asymptomatic cases to being fatal in others. The need of the hour is to find meaningful and cost-effective COVID-19 biomarkers out of conventional hematological and biochemical parameters, which will help in the early identification of patients with a poor prognosis, leading to timely intervention. Aim: The aim was to analyze different biochemical and hematological parameters in COVID-19 patients and also to study the association of these parameters with disease severity. Materials and Methods: Cross-sectional observational study was carried out on 100 COVID-19 patients from a hospital from July to October 2020. Based on saturation of oxygen (SpO[sub.2]), admitted patients were grouped into mild-moderate (SpO[sub.2] ≥90) and severe groups (SpO[sub.2]
ISSN:2213-879X
DOI:10.4103/jmau.jmau_59_22